Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    LAMIVUDINE; ZIDOVUDINE

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Aurobindo Pharma Limited

    02 1Chartwell Pharmaceuticals llc

    03 3Cipla

    04 1Emcure Pharmaceuticals

    05 1Epic Pharma. LLC.

    06 1Farm Agon

    07 2Hetero Drugs

    08 1Lupin Ltd

    09 1Macleods Pharmaceuticals Limited

    10 1Natco Pharma

    11 1Norvium

    12 1ORIFARM GROUP AS

    13 1PHARMOBEDIENT

    14 1Pharmacare Premium

    15 1Teva Pharmaceutical Industries

    16 3Viatris

    17 4ViiV Healthcare

    18 1Zim Laboratories

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Aurobindo Pharma Limited

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE; ZIDOVUDINE

    Dosage Form : TABLET; ORAL

    Dosage Strength : 30MG; 60MG

    Packaging :

    Approval Date :

    Application Number : 22296

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Aurobindo Pharma Limited

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2017-05-05

    Application Number : 77558

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Aurobindo Pharma Limited

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2012-05-15

    Application Number : 202418

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Chartwell Pharmaceuticals llc

    U.S.A
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Chartwell Pharmaceuticals llc

    U.S.A
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2011-05-25

    Application Number : 79081

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Cipla

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Cipla

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2018-09-07

    Application Number : 77411

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Cipla

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Cipla

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE; ZIDOVUDINE

    Dosage Form : TABLET; ORAL

    Dosage Strength : 30MG; 60MG

    Packaging :

    Approval Date :

    Application Number : 201151

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Cipla

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Cipla

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE; ZIDOVUDINE

    Dosage Form : TABLET, FOR SUSPENSION; ORAL

    Dosage Strength : 30MG; 60MG

    Packaging :

    Approval Date :

    Application Number : 202814

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Emcure Pharmaceuticals

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Emcure Pharmaceuticals

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE; ZIDOVUDINE

    Dosage Form : TABLET; ORAL

    Dosage Strength : 150MG; 300MG

    Packaging :

    Approval Date :

    Application Number : 78929

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Epic Pharma. LLC.

    U.S.A
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Epic Pharma. LLC.

    U.S.A
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2018-04-10

    Application Number : 206375

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Hetero Drugs

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2015-09-17

    Application Number : 79124

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Hetero Drugs

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2014-02-03

    Application Number : 203259

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Lupin Ltd

    India
    arrow
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2012-05-15

    Application Number : 90246

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Macleods Pharmaceuticals Limited

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Macleods Pharmaceuticals Limited

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2018-08-29

    Application Number : 90679

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Natco Pharma

    India
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2014-08-28

    Application Number : 204005

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Norvium

    U.S.A
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Norvium

    U.S.A
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2015-05-13

    Application Number : 79128

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Pharmacare Premium

    Malta
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Pharmacare Premium

    Malta
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Malta
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2017-03-17

    Application Number : 22018

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Viatris

    U.S.A
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE; ZIDOVUDINE

    Dosage Form : TABLET; ORAL

    Dosage Strength : 30MG; 60MG

    Packaging :

    Approval Date :

    Application Number : 200748

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Viatris

    U.S.A
    ISPOR Europe 2025
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE; ZIDOVUDINE

    Dosage Form : TABLET; ORAL SUSPENSION

    Dosage Strength : 30MG; 60MG

    Packaging :

    Approval Date :

    Application Number : 204914

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    ViiV Healthcare

    United Kingdom
    ISPOR Europe 2025
    Not Confirmed
    arrow

    ViiV Healthcare

    United Kingdom
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : COMBIVIR

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 1997-09-26

    Application Number : 20857

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    PHARMOBEDIENT

    Country
    ISPOR Europe 2025
    Not Confirmed
    arrow

    PHARMOBEDIENT

    Country
    arrow
    ISPOR Europe 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LAMIVUDINE; ZIDOVUDINE

    Brand Name : LAMIVUDINE AND ZIDOVUDINE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG;300MG

    Packaging :

    Approval Date : 2019-08-12

    Application Number : 79079

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF